STAT4-associated natural killer cell tolerance following liver transplantation
Objective Natural killer (NK) cells are important mediators of liver inflammation in chronic liver disease. The aim of this study was to investigate why liver transplants (LTs) are not rejected by NK cells in the absence of human leukocyte antigen (HLA) matching, and to identify a tolerogenic NK cell phenotype. Design Phenotypic and functional analyses on NK cells from 54 LT recipients were performed, and comparisons made with healthy controls. Further investigation was performed using gene expression analysis and donor:recipient HLA typing. Results NK cells from non-HCV LT recipients were hypofunctional, with reduced expression of NKp46 (p<0.05) and NKp30 (p<0.001), reduced cytotoxicity (p<0.001) and interferon (IFN)-[GAMMA] secretion (p<0.025). There was no segregation of this effect with HLA-C, and these functional changes were not observed in individuals with HCV. Microarray and RT-qPCR analysis demonstrated downregulation of STAT4 in NK cells from LT recipients (p<0.0001). Changes in the expression levels of the transcription factors Helios (p=0.06) and Hobit (p=0.07), which control NKp46 and IFN[GAMMA] expression, respectively, were also detected. Hypofunctionality of NK cells was associated with impaired STAT4 phosphorylation and downregulation of the STAT4 target microRNA-155. Conversely in HCV-LT NK cell tolerance was reversed, consistent with the more aggressive outcome of LT for HCV. Conclusions LT is associated with transcriptional and functional changes in NK cells, resulting in reduced activation. NK cell tolerance occurs upstream of major histocompatibility complex (MHC) class I mediated education, and is associated with deficient STAT4 phosphorylation. STAT4 therefore represents a potential therapeutic target to induce NK cell tolerance in liver disease..
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2017 |
|---|---|
| Erschienen: |
2017 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:66 |
|---|---|
| Enthalten in: |
Gut - 66(2017), 2, Seite 352-361 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Jamil, K M [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Acquisitions & mergers |
|---|
| doi: |
10.1136/gutjnl-2015-309395 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
OLC1990651674 |
|---|
| LEADER | 01000caa a2200265 4500 | ||
|---|---|---|---|
| 001 | OLC1990651674 | ||
| 003 | DE-627 | ||
| 005 | 20230715032332.0 | ||
| 007 | tu | ||
| 008 | 170303s2017 xx ||||| 00| ||eng c | ||
| 024 | 7 | |a 10.1136/gutjnl-2015-309395 |2 doi | |
| 028 | 5 | 2 | |a PQ20170721 |
| 035 | |a (DE-627)OLC1990651674 | ||
| 035 | |a (DE-599)GBVOLC1990651674 | ||
| 035 | |a (PRQ)c2140-570aa4615dd535a843b59c109c73e559e95dc44c00d6e9e7c97001e135f423b50 | ||
| 035 | |a (KEY)0064913920170000066000200352stat4associatednaturalkillercelltolerancefollowing | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q DNB |
| 100 | 1 | |a Jamil, K M |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a STAT4-associated natural killer cell tolerance following liver transplantation |
| 264 | 1 | |c 2017 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 520 | |a Objective Natural killer (NK) cells are important mediators of liver inflammation in chronic liver disease. The aim of this study was to investigate why liver transplants (LTs) are not rejected by NK cells in the absence of human leukocyte antigen (HLA) matching, and to identify a tolerogenic NK cell phenotype. Design Phenotypic and functional analyses on NK cells from 54 LT recipients were performed, and comparisons made with healthy controls. Further investigation was performed using gene expression analysis and donor:recipient HLA typing. Results NK cells from non-HCV LT recipients were hypofunctional, with reduced expression of NKp46 (p<0.05) and NKp30 (p<0.001), reduced cytotoxicity (p<0.001) and interferon (IFN)-[GAMMA] secretion (p<0.025). There was no segregation of this effect with HLA-C, and these functional changes were not observed in individuals with HCV. Microarray and RT-qPCR analysis demonstrated downregulation of STAT4 in NK cells from LT recipients (p<0.0001). Changes in the expression levels of the transcription factors Helios (p=0.06) and Hobit (p=0.07), which control NKp46 and IFN[GAMMA] expression, respectively, were also detected. Hypofunctionality of NK cells was associated with impaired STAT4 phosphorylation and downregulation of the STAT4 target microRNA-155. Conversely in HCV-LT NK cell tolerance was reversed, consistent with the more aggressive outcome of LT for HCV. Conclusions LT is associated with transcriptional and functional changes in NK cells, resulting in reduced activation. NK cell tolerance occurs upstream of major histocompatibility complex (MHC) class I mediated education, and is associated with deficient STAT4 phosphorylation. STAT4 therefore represents a potential therapeutic target to induce NK cell tolerance in liver disease. | ||
| 650 | 4 | |a Transplantation | |
| 650 | 4 | |a Diagnosis | |
| 650 | 4 | |a Liver diseases | |
| 650 | 4 | |a Liver | |
| 650 | 4 | |a Research | |
| 650 | 4 | |a Killer cells | |
| 650 | 4 | |a Usage | |
| 650 | 4 | |a Transplants & implants | |
| 650 | 4 | |a Cytotoxicity | |
| 650 | 4 | |a Acquisitions & mergers | |
| 650 | 4 | |a Bone marrow | |
| 650 | 4 | |a Cytokines | |
| 650 | 4 | |a Studies | |
| 650 | 4 | |a T cell receptors | |
| 650 | 4 | |a Ligands | |
| 700 | 1 | |a Hydes, T J |4 oth | |
| 700 | 1 | |a Cheent, K S |4 oth | |
| 700 | 1 | |a Cassidy, S A |4 oth | |
| 700 | 1 | |a Traherne, J A |4 oth | |
| 700 | 1 | |a Jayaraman, J |4 oth | |
| 700 | 1 | |a Trowsdale, J |4 oth | |
| 700 | 1 | |a Alexander, G J |4 oth | |
| 700 | 1 | |a Little, A-M |4 oth | |
| 700 | 1 | |a McFarlane, H |4 oth | |
| 700 | 1 | |a Heneghan, M A |4 oth | |
| 700 | 1 | |a Purbhoo, M A |4 oth | |
| 700 | 1 | |a Khakoo, S I |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Gut |d London : BMJ Publishing Group, 1960 |g 66(2017), 2, Seite 352-361 |w (DE-627)129269301 |w (DE-600)80128-8 |w (DE-576)014459752 |x 0017-5749 |7 nnns |
| 773 | 1 | 8 | |g volume:66 |g year:2017 |g number:2 |g pages:352-361 |
| 856 | 4 | 1 | |u http://dx.doi.org/10.1136/gutjnl-2015-309395 |3 Volltext |
| 856 | 4 | 2 | |u https://search.proquest.com/docview/1863569545 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 912 | |a GBV_ILN_4012 | ||
| 912 | |a GBV_ILN_4126 | ||
| 912 | |a GBV_ILN_4219 | ||
| 951 | |a AR | ||
| 952 | |d 66 |j 2017 |e 2 |h 352-361 | ||